Black Friday saleUp to 70% OFF
ORCHID PHARMA LIMITEDORCHID PHARMA LIMITEDORCHID PHARMA LIMITED

ORCHID PHARMA LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ORCHPHARMA chart


Full chart

ORCHPHARMA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪79.90 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
67.15
Basic EPS (TTM)
23.45 INR
Net income (FY)
‪921.66 M‬ INR
Revenue (FY)
‪8.19 B‬ INR
Shares float
‪13.37 M‬
Beta (1Y)
1.40

Employees


Employees (FY)
923
Change (1Y)
−35 −3.65%
Revenue / Employee (1Y)
‪106.39 K‬ INR
Net income / Employee (1Y)
‪11.97 K‬ INR

About ORCHID PHARMA LTD


Sector
Health Technology
CEO
Manish Dhanuka
Headquarters
Narsinghpur
Website
orchidpharma.com
Founded
1992
ISIN
INE191A01027
FIGI
BBG000CX8059
Orchid Pharma Ltd. engages in the provision of development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectables, veterinary products, and non-antibiotics. The company was founded by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Narsinghpur, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ORCHPHARMA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ORCHPHARMA is 1,626.00 INR — it has increased by 3.22% in the past 24 hours. Watch ORCHID PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ORCHID PHARMA LIMITED stocks are traded under the ticker ORCHPHARMA.
ORCHPHARMA stock has risen by 13.88% compared to the previous week, the month change is a 24.22% rise, over the last year ORCHID PHARMA LIMITED has showed a 119.34% increase.
We've gathered analysts' opinions on ORCHID PHARMA LIMITED future price: according to them, ORCHPHARMA price has a max estimate of 1,823.00 INR and a min estimate of 1,710.00 INR. Watch ORCHPHARMA chart and read a more detailed ORCHID PHARMA LIMITED stock forecast: see what analysts think of ORCHID PHARMA LIMITED and suggest that you do with its stocks.
ORCHPHARMA reached its all-time high on Aug 13, 2024 with the price of 1,591.55 INR, and its all-time low was 702.30 INR and was reached on Jan 18, 2024. View more price dynamics on ORCHPHARMA chart.
See other stocks reaching their highest and lowest prices.
ORCHPHARMA stock is 4.66% volatile and has beta coefficient of 1.40. Track ORCHID PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is ORCHID PHARMA LIMITED there?
Today ORCHID PHARMA LIMITED has the market capitalization of ‪79.90 B‬, it has increased by 3.74% over the last week.
Yes, you can track ORCHID PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
ORCHID PHARMA LIMITED is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ORCHPHARMA net income for the last quarter is ‪272.37 M‬ INR, while the quarter before that showed ‪293.51 M‬ INR of net income which accounts for −7.20% change. Track more ORCHID PHARMA LIMITED financial stats to get the full picture.
No, ORCHPHARMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 923.00 employees. See our rating of the largest employees — is ORCHID PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORCHID PHARMA LIMITED EBITDA is ‪1.27 B‬ INR, and current EBITDA margin is 13.54%. See more stats in ORCHID PHARMA LIMITED financial statements.
Like other stocks, ORCHPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORCHID PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORCHID PHARMA LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORCHID PHARMA LIMITED stock shows the strong buy signal. See more of ORCHID PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.